Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Levoin

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|January 13, 2017
Sketching of CD95 Oligomers by In Silico InvestigationsNicolas Levoin
Frontiers in Cell and Developmental Biology|May 21, 2020
CD95 Structure, Aggregation and Cell SignalingNicolas Levoin, Mickael Jean, Patrick Legembre
Bioorganic & Medicinal Chemistry|January 30, 2002
Synthesis and biological testing of Acyl-CoA-ketoprofen conjugates as selective irreversible inhibitors of COX-2Nicolas Levoin, Françoise Chrétien, Françoise Lapicque, et al.
Organic Letters|December 2, 2011
The Prins reaction using ketones: rationalization and application toward the synthesis of the portentol skeletonMaiwenn Jacolot, Mickael Jean, Nicolas Levoin, et al.
The Journal of Biological Chemistry|May 3, 2002
The donor substrate specificity of the human beta 1,3-glucuronosyltransferase I toward UDP-glucuronic acid is determined by two crucial histidine and arginine residuesMohamed Ouzzine, Sandrine Gulberti, Nicolas Levoin, et al.
Bioorganic & Medicinal Chemistry Letters|March 8, 2014
Design, synthesis and biological evaluation of new inhibitors of Bax/Bcl-xL interaction in cancer cellsDuc Duy Vo, Fabien Gautier, Sophie Barillé-Nion, et al.
Bioorganic & Medicinal Chemistry|March 24, 2015
A combination of in silico and SAR studies to identify binding hot spots of Bcl-xL inhibitorsNicolas Levoin, Duc Duy Vo, Fabien Gautier, et al.
European Journal of Immunology|October 14, 2023
CD95L concatemers highlight different stoichiometries of CD95-mediated apoptotic and nonapoptotic pathwaysEden Lebrault, Christelle Oblet, Keerthi Kurma, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 9, 2008
A solid phase parallel synthesis of diverse amides as dopamine D3 receptor ligandsMickaël Jean, Jacques Renault, Jean-Claude Camelin, et al.
Bioorganic & Medicinal Chemistry Letters|September 19, 2019
Probing the side chain tolerance for inhibitors of the CD95/PLCγ1 interactionHa Thanh Nguyen, Jean-Philippe Guégan, Daniel Best, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|January 13, 2017
Sketching of CD95 Oligomers by In Silico InvestigationsNicolas Levoin
Frontiers in Cell and Developmental Biology|May 21, 2020
CD95 Structure, Aggregation and Cell SignalingNicolas Levoin, Mickael Jean, Patrick Legembre
Bioorganic & Medicinal Chemistry|January 30, 2002
Synthesis and biological testing of Acyl-CoA-ketoprofen conjugates as selective irreversible inhibitors of COX-2Nicolas Levoin, Françoise Chrétien, Françoise Lapicque, et al.
Organic Letters|December 2, 2011
The Prins reaction using ketones: rationalization and application toward the synthesis of the portentol skeletonMaiwenn Jacolot, Mickael Jean, Nicolas Levoin, et al.
The Journal of Biological Chemistry|May 3, 2002
The donor substrate specificity of the human beta 1,3-glucuronosyltransferase I toward UDP-glucuronic acid is determined by two crucial histidine and arginine residuesMohamed Ouzzine, Sandrine Gulberti, Nicolas Levoin, et al.
Bioorganic & Medicinal Chemistry Letters|March 8, 2014
Design, synthesis and biological evaluation of new inhibitors of Bax/Bcl-xL interaction in cancer cellsDuc Duy Vo, Fabien Gautier, Sophie Barillé-Nion, et al.
Bioorganic & Medicinal Chemistry|March 24, 2015
A combination of in silico and SAR studies to identify binding hot spots of Bcl-xL inhibitorsNicolas Levoin, Duc Duy Vo, Fabien Gautier, et al.
European Journal of Immunology|October 14, 2023
CD95L concatemers highlight different stoichiometries of CD95-mediated apoptotic and nonapoptotic pathwaysEden Lebrault, Christelle Oblet, Keerthi Kurma, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 9, 2008
A solid phase parallel synthesis of diverse amides as dopamine D3 receptor ligandsMickaël Jean, Jacques Renault, Jean-Claude Camelin, et al.
Bioorganic & Medicinal Chemistry Letters|September 19, 2019
Probing the side chain tolerance for inhibitors of the CD95/PLCγ1 interactionHa Thanh Nguyen, Jean-Philippe Guégan, Daniel Best, et al.
Pageof 4